Bone Biologics Corp (BBLG) shareholders
Close on Nov 18, 2026Market cap $986.22KP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Intracoastal Capital LLC Joint filing with Mitchell P. Kopin (9.99%), Daniel B. Asher (9.99%) | 305,888 | 9.99% | 13G (passive) amendment | Sep 30, 2026 |
| Daniel B. Asher Joint filing with Mitchell P. Kopin (9.99%), Intracoastal Capital LLC (9.99%) | 199,251 | 9.99% | 13G (passive) amendment | Sep 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BBLG | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 23,879 | 0.70% | $32.71K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 1,953 | 0.06% | $2.68K | −2,173 | 0.00% |
| SBI Securities Co., Ltd. | 230 | 0.01% | $315 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 3 | 0M | 0.8% | 1 / 0 | 1 / 1 | 0M | 0M |
| Q1 2026 | 3 | 0M | 0.1% | 0 / 1 | 1 / 4 | 0M | 0M |
| Q4 2025 | 7 | 0M | 1.5% | 2 / 3 | 0 / 2 | 0M | 0M |
| Q3 2025 | 7 | 0M | 0.4% | 4 / 2 | 1 / 0 | 0M | 0M |
| Q2 2025 | 4 | 0M | 0.0% | 4 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
3 funds held BBLG in Q1 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of BBLG | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 7,810 | 0.23% | $10.31K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 656 | 0.02% | $866 | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jeff Frelick | Chief Executive Officer | 360 | 0.01% | Jan 21, 2026 |
| Deina H. Walsh | Chief Financial Officer | 313 | 0.01% | Jan 21, 2026 |
| Robert E. Gagnon | Director | 0 | – | Sep 30, 2026 |
| Phillip Terry Meikle II | Director | – | – | Sep 30, 2026 |
| Bruce Stroever | Director | 0 | – | Sep 30, 2026 |
| Siddhesh Rajendra Angle | Director | – | – | Sep 30, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Deina H. Walsh Chief Financial Officer | Sep 13, 2023 | Buy | +8,000 | $0.64 | $5.12K | 15,000 |
| Jeff Frelick Chief Executive Officer | Sep 11, 2023 | Buy | +9,500 | $0.69 | $6.55K | 17,204 |
| Deina H. Walsh Chief Financial Officer | Sep 6, 2023 | Buy | +300 | $0.70 | $210 | 300 |
| Deina H. Walsh Chief Financial Officer | Sep 6, 2023 | Buy | +6,700 | $0.71 | $4.76K | 7,000 |
| Jeff Frelick Chief Executive Officer | Aug 31, 2023 | Buy | +7,600 | $0.66 | $5.02K | 7,704 |
| Knight Insurance Company, Ltd 10% owner | Mar 13, 2023 | Other | −500,137 | – | – | 0 |
| Hankey Capital, Llc 10% owner | Oct 15, 2021 | Conversion | −9,361,702 | – | – | 7,553,922 |
| Hankey Capital, Llc 10% owner | Oct 15, 2021 | Gift | −1,004,310 | – | – | 7,025,802 |
| Hankey Capital, Llc 10% owner | Oct 15, 2021 | Discretionary | +476,190 | $5.24 | $2.50M | 8,030,112 |
| Hankey Capital, Llc 10% owner | Oct 15, 2021 | Conversion | +5,928,774 | $2.50 | $14.82M | 16,915,624 |
| Hankey Trust Don – | Jan 2, 2020 | Buy | +195,000 | $1.00 | $195.00K | 28,563,398 |
| Bret Hankey Director | Jan 2, 2020 | Buy | +195,000 | $1.00 | $195.00K | 28,122,518 |
| Bret Hankey Director | Aug 6, 2019 | Buy | +553,191 | – | – | 27,829,860 |
| Hankey Trust Don – | Aug 6, 2019 | Buy | +553,191 | – | – | 28,465,740 |
| Bret Hankey Director | Jul 15, 2019 | Buy | +85,106 | – | – | – |
| Hankey Capital, Llc 10% owner | Jul 15, 2019 | Buy | +85,106 | – | – | 27,912,549 |
| Hankey Trust Don – | Jun 20, 2019 | Buy | +1,063,830 | – | – | – |
| Bret Hankey Director | Jun 20, 2019 | Buy | +1,063,830 | – | – | 27,191,563 |
| Don Hankey Chairman of the Board, Director, 10% owner | May 7, 2019 | Buy | +1,063,830 | – | – | 26,763,613 |
| Bret Hankey Director | May 7, 2019 | Buy | +1,063,830 | – | – | 26,127,733 |
| Hankey Capital, Llc 10% owner | Mar 25, 2019 | Buy | +1,489,362 | – | – | 25,699,783 |
| Bret Hankey Director | Mar 25, 2019 | Buy | +1,489,362 | – | – | 25,063,903 |
| Hankey Capital, Llc 10% owner | Dec 17, 2018 | Buy | +18,009,696 | – | – | 24,210,421 |
| Bret Hankey Director | Dec 17, 2018 | Buy | +18,009,696 | – | – | 23,013,754 |
| AFH Holding & Advisory, LLC 10% owner | Nov 29, 2017 | Other | +915,614 | – | – | 2,942,393 |
| AFH Holding & Advisory, LLC 10% owner | Sep 7, 2017 | Other | +1,826,779 | – | – | 1,826,779 |
| AFH Holding & Advisory, LLC 10% owner | Sep 7, 2017 | Other | +200,000 | – | – | 2,026,779 |
| AFH Holding & Advisory, LLC 10% owner | Sep 7, 2017 | Other | −1,826,779 | – | – | 1,941,579 |
| AFH Holding & Advisory, LLC 10% owner | Jul 14, 2016 | Returned to company | −5,000 | $5.00 | $25.00K | 3,768,358 |
| Amir F. Heshmatpour Director | Jul 6, 2016 | Award | +23,173 | $5.00 | $115.87K | 3,773,358 |
| Amir F. Heshmatpour Director | Jul 6, 2016 | Award | +20,186 | $5.00 | $100.93K | 3,750,185 |
| Amir F. Heshmatpour 10% owner | May 20, 2016 | Other | −915,614 | $4.95 | $4.53M | 3,729,999 |
| Musculoskeletal Transplant Foundation, Inc. 10% owner | Feb 29, 2016 | Buy | +731,707 | $2.05 | $1.50M | 11,640,096 |
| AFH Holding & Advisory, LLC 10% owner | Feb 9, 2016 | Award | +1,260,255 | – | – | 4,645,613 |
| John J. Booth Director | Dec 31, 2015 | Gift | −20,000 | – | – | 20,822 |
| Steve B. Warnecke Director | Dec 31, 2015 | Gift | −59,375 | – | – | 0 |
| George A. Oram Director | Dec 28, 2015 | Award | +40,822 | – | – | 40,822 |
| B. Chia Soo Director | Dec 28, 2015 | Award | +9,176 | – | – | 2,988,078 |
| John J. Booth Director | Dec 28, 2015 | Award | +9,176 | – | – | 40,822 |
| Jim Delshad Director | Dec 28, 2015 | Award | +9,176 | – | – | 40,822 |
| Steve B. Warnecke Director | Dec 28, 2015 | Award | +27,729 | – | – | 59,375 |
| William F. Coffin Director | Dec 28, 2015 | Award | +9,176 | – | – | 40,822 |
| B. Chia Soo Director | Dec 22, 2015 | Sale | −5,274 | $1.58 | $8.33K | 2,982,804 |
| Benjamin Wu Director | Dec 22, 2015 | Sale | −2,637 | $1.58 | $4.17K | 970,991 |
| AFH Holding & Advisory, LLC 10% owner | Nov 20, 2015 | Sale | −7,911 | $1.58 | $12.50K | 3,385,358 |
| AFH Holding & Advisory, LLC 10% owner | Oct 27, 2015 | Award | +915,614 | – | – | 3,393,269 |
| B. Chia Soo Director | Oct 22, 2015 | Gift | −2,000,000 | – | – | 0 |
| B. Chia Soo Director | Oct 22, 2015 | Gift | +2,000,000 | – | – | 2,978,902 |
| AFH Holding & Advisory, LLC 10% owner | Oct 19, 2015 | Award | +5,000 | $1.58 | $7.90K | 2,477,655 |
| Benjamin Wu Director | Oct 9, 2015 | Sale | −26,372 | $1.58 | $41.67K | 973,628 |
| Musculoskeletal Transplant Foundation, Inc. Director | Oct 9, 2015 | Sale | −26,372 | $1.58 | $41.67K | 973,628 |
| B. Chia Soo Director | Oct 9, 2015 | Sale | −52,744 | $1.58 | $83.34K | 978,902 |
| Amir F. Heshmatpour 10% owner | Oct 9, 2015 | Sale | −79,110 | $1.58 | $124.99K | 2,472,655 |
| Steve B. Warnecke Director | Sep 19, 2015 | Award | +31,646 | – | – | 31,646 |
| B. Chia Soo Director | Sep 19, 2015 | Award | +31,646 | – | – | 1,031,646 |
| John J. Booth Director | Sep 19, 2015 | Award | +31,646 | – | – | 31,646 |
| Jim Delshad Director | Sep 19, 2015 | Award | +31,646 | – | – | 31,646 |
| William F. Coffin Director | Sep 19, 2015 | Award | +31,646 | – | – | 31,646 |
| Amir F. Heshmatpour 10% owner | Sep 9, 2015 | Gift | −100,000 | – | – | 2,751,765 |
| Amir F. Heshmatpour 10% owner | Sep 9, 2015 | Gift | −100,000 | – | – | 2,651,765 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Bone Biologics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 45,868 shares on Sep 18, 2026 over the last 90 days.
See a number that looks wrong?